You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
和邦生物(603077.SH)2019年淨利預增40%-60%
格隆匯 01-20 16:19

格隆匯1月20日丨和邦生物(603077.SH)發佈2019年度業績預告,預計2019年年度實現歸屬於上市公司股東的淨利潤與上年同期相比,將增加1.45-2.18億元,同比增加40%-60%。歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期(法定披露數據)相比,將增加1.37-1.998億元,同比增加37%-55%。

報告期內,歸屬於上市公司股東的淨利潤較上年同期上升,主要原因是:本年度公司聯鹼產品產量較上年同期有所增加,經過進一步對生產成本的控制,提升了產品的毛利率。同時,公司的海外子公司經過管理調整,經營情況較上年度逐步好轉,使得本年度淨利潤增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account